“HER2 Breast Cancer Talk”: A Review of Data from the SABCS 2020 Virtual Symposium - Episode 1

Current Treatment Landscape for HER2+ Breast Cancer

, , ,
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Breast cancer experts discuss the evolution of HER2-targeted treatments, including margetuximab, trastuzumab, tucatinib, and neratinib, along with unmet needs in patients with HER2+ breast cancer.

    x